Pharmacokinetics of polymyxin B in an infant with multidrug-resistant Klebsiella pneumoniae bacteremia.
Pediatr Infect Dis J
; 30(6): 537-9, 2011 Jun.
Article
in En
| MEDLINE
| ID: mdl-21164382
ABSTRACT
We report our experience with a 9-month-old infant treated with intravenous polymyxin B for multidrug-resistant Klebsiella pneumoniae bacteremia. Serial blood samples were obtained at steady state and serum drug concentrations were determined using a validated liquid chromatography-mass spectrometry method. The elimination half-lives of polymyxin B1 and isoleucine-polymyxin B1 were found to be 3.1 and 4.7 hours, respectively.
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Polymyxin B
/
Klebsiella Infections
/
Bacteremia
/
Drug Resistance, Multiple, Bacterial
/
Klebsiella pneumoniae
/
Anti-Bacterial Agents
Limits:
Female
/
Humans
/
Infant
Language:
En
Journal:
Pediatr Infect Dis J
Journal subject:
DOENCAS TRANSMISSIVEIS
/
PEDIATRIA
Year:
2011
Document type:
Article
Affiliation country:
Estados Unidos